VanaCof 2 by is a Otc medication manufactured, distributed, or labeled by GM Pharmaceuticals, INC. Drug facts, warnings, and ingredients follow.
■ a cough that lasts or is chronic such as occurs with smoking, asthma, or emphysema
■ a cough that occurs with too much phlegm (mucus)
■ a breathing problem such as emphysema or chronic bronchitis
■ trouble urinating due to an enlarged prostate gland
■ glaucoma
■ excitability may occur, especially in children
■ may cause marked drowsiness
■ alcohol, sedatives, and tranquilizers may increase the drowsiness effect
■ avoid alcoholic drinks
■ use caution when driving a motor vehicle or operating machinery
do not exceed recommended dosage.
adults and children 12 years of age and over: |
2 teaspoonfuls (10 mL) every 6 hours, not to exceed 8 teaspoonfuls
|
children 6 to under 12 years of age: |
1 teaspoonful (5 mL) every 6 hours, not to exceed 4 teaspoonfuls
|
children under 6 years of age: | consult a doctor. |
NDC: 58809-190-16
VanaCof® 2
EACH 5 mL (1 TEASPOONFUL) CONTAINS:
Chlophedianol HCI..........................12.5 mg
Dexchlorpheniramine Maleate............1 mg
Cough Suppressant
Antihistamine
Sugar Free, Alcohol Free, Dye Free
Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.
THIS BOTTLE IS NOT TO BE DISPENSED TO CONSUMER.
Dispense in a tight, light-resistant container with a child-resistant cap.
US Patent # 9,463,191
US Patent # 9,050,289
GM Pharmaceuticals, Inc.
16 fl. oz. (473 mL)
VANACOF 2
chlophedianol hcl, dexchlorpheniramine maleate solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - GM Pharmaceuticals, INC (793000860) |